226 related articles for article (PubMed ID: 26266536)
21. Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3.
Li QF; Cheng HL; Yang L; Ma Y; Zhao JJ; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Sep; 8(9):e1314. PubMed ID: 32643267
[TBL] [Abstract][Full Text] [Related]
22. Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala.
Martins S; Soong BW; Wong VC; Giunti P; Stevanin G; Ranum LP; Sasaki H; Riess O; Tsuji S; Coutinho P; Amorim A; Sequeiros J; Nicholson GA
Arch Neurol; 2012 Jun; 69(6):746-51. PubMed ID: 22351852
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
25. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India.
Basu P; Chattopadhyay B; Gangopadhaya PK; Mukherjee SC; Sinha KK; Das SK; Roychoudhury S; Majumder PP; Bhattacharyya NP
Hum Genet; 2000 Jun; 106(6):597-604. PubMed ID: 10942107
[TBL] [Abstract][Full Text] [Related]
26. Protocol for the Characterization of the Cytosine-Adenine-Guanine Tract and Flanking Polymorphisms in Machado-Joseph Disease: Impact on Diagnosis and Development of Gene-Based Therapies.
Lopes SM; Faro R; Lopes MM; Onofre I; Mendonça N; Ribeiro J; Januário C; Nobre RJ; Pereira de Almeida L
J Mol Diagn; 2020 Jun; 22(6):782-793. PubMed ID: 32205289
[TBL] [Abstract][Full Text] [Related]
27. [Identification of ATXN3 intermedial allele associated with a disease phenotype in an SCA3 Han Chinese family].
Yu J; Ma JH; Zhang XN; Lei J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):190-3. PubMed ID: 20376803
[TBL] [Abstract][Full Text] [Related]
28. Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation.
Mitchell N; LaTouche GA; Nelson B; Figueroa KP; Walker RH; Sobering AK
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31565539
[TBL] [Abstract][Full Text] [Related]
29. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
30. Absence of spinocerebellar ataxia type 3/Machado-Joseph disease within ataxic patients in the Czech population.
Bauer PO; Zumrova A; Matoska V; Marikova T; Krilova S; Boday A; Singh B; Goetz P
Eur J Neurol; 2005 Nov; 12(11):851-7. PubMed ID: 16241973
[TBL] [Abstract][Full Text] [Related]
31. The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis.
Chatterjee A; Saha S; Chakraborty A; Silva-Fernandes A; Mandal SM; Neves-Carvalho A; Liu Y; Pandita RK; Hegde ML; Hegde PM; Boldogh I; Ashizawa T; Koeppen AH; Pandita TK; Maciel P; Sarkar PS; Hazra TK
PLoS Genet; 2015 Jan; 11(1):e1004749. PubMed ID: 25633985
[TBL] [Abstract][Full Text] [Related]
32. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
33. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
34. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the CAG repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese Han].
Wang J; Xu Q; Lei L; Shen L; Jiang H; Li X; Zhou Y; Yi J; Zhou J; Yan X; Pan Q; Xia K; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):620-5. PubMed ID: 19953482
[TBL] [Abstract][Full Text] [Related]
36. Improvement in the molecular diagnosis of Machado-Joseph disease.
Maciel P; Costa MC; Ferro A; Rousseau M; Santos CS; Gaspar C; Barros J; Rouleau GA; Coutinho P; Sequeiros J
Arch Neurol; 2001 Nov; 58(11):1821-7. PubMed ID: 11708990
[TBL] [Abstract][Full Text] [Related]
37. The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.
Zhou Q; Ni W; Dong Y; Wang N; Gan SR; Wu ZY
PLoS One; 2014; 9(11):e111356. PubMed ID: 25369462
[TBL] [Abstract][Full Text] [Related]
38. Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project.
Akçimen F; Ross JP; Liao C; Spiegelman D; Dion PA; Rouleau GA
Mov Disord; 2021 Feb; 36(2):514-518. PubMed ID: 33159825
[TBL] [Abstract][Full Text] [Related]
39. Establishment of human-induced pluripotent stem cell GZHMCi0011-A from peripheral blood mononuclear cells from a volunteer with 14/63 CAG repeats of the ATXN3 mutation.
Hongmei G; Xiaofang S; Bing S
Stem Cell Res; 2023 Oct; 72():103190. PubMed ID: 37866221
[TBL] [Abstract][Full Text] [Related]
40. The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Bettencourt C; Santos C; Montiel R; Kay T; Vasconcelos J; Maciel P; Lima M
Eur J Hum Genet; 2010 May; 18(5):621-3. PubMed ID: 19935829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
